Nan Fung Group Holdings’s BioCryst Pharmaceuticals BCRX Stock Holding History

Nan Fung Group Holdings’s Portfolio BCRX Stock Details BCRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell
2024 Q1	$187K	Buy
2023 Q4	$107K	Hold
2023 Q3	$126K	Hold
2023 Q2	$126K	Hold
2023 Q1	$149K	Buy
2022 Q1	–	Sell
2021 Q4	$215K	Buy